Good news! Beijing Jinhao Pharmaceutical has been included in the first batch of Beijing municipal-level enterprise technology center establishment list for 2022.
发布时间：2022.10.24
Recently, Beijing Jinhao Pharmaceutical Co., Ltd. (hereinafter referred to as “Jinhao Pharmaceutical”) was included in the first batch of the 2022 list of municipal-level enterprise technology centers in Beijing. A total of 96 enterprises were selected, with 15 hailing from the Beijing Economic-Technological Development Area, among which Jinhao Pharmaceutical is one.
The designation of an Enterprise Technology Center is a prestigious R&D‑platform credential conferred by the Beijing Municipal Government to enterprises that demonstrate strong technological innovation capabilities, achieve notable innovation outcomes, and serve as important models and guides. Establishing an Enterprise Technology Center is a key initiative of the Beijing Municipal Bureau of Economy and Information Technology aimed at fostering the development of high‑end, sophisticated, and cutting‑edge industries, while identifying and nurturing more exemplary enterprises with robust innovation capacity and effective innovation mechanisms.
Jinhao Pharmaceutical’s inclusion on this list underscores the Beijing Municipal Government’s high regard for our company’s research capabilities and technological innovation. Within the biopharmaceutical and greater health industry value chain, Jinhao Pharmaceutical will continue to strive for excellence, relentlessly pursue technological breakthroughs, strengthen both corporate and product competitiveness, and contribute to regional industrial innovation and economic development.
Follow us
Phone: 400-650-6787 | 010-67878866 | Address: Building 1, No. 7 Yuncheng Street, Beijing Economic-Technological Development Area, Beijing |
© 2026 Beijing Jinhao Pharmaceutical Co., Ltd. All rights reserved | Beijing ICP Filing No. 17020135-2